In summary, stem cells overexpressing DCN can improve the local cellular microenvironment in pulmonary fibrosis by regulating local and systemic inflammation levels and ultimately reducing fibrous deposition to achieve the effect of treating pulmonary fibrosis. This evidence concerns the gene DCN and pulmonary fibrosis.